Remove Drug Development Remove Health Technology Remove HIE
article thumbnail

Blockchain in Healthcare: A Vehicle Towards Digital Health 2.0?

The Digital Health Corner

Blockchain can also ensure the accuracy of the data exchanged among entities, something a HIE (health information exchange) cannot do. Blockchain technology’s potential impact on the life sciences industry (drug development, distribution and prescribing) is significant.

article thumbnail

Future HealthTech Valuations in 2025: A Dynamic Landscape

Lloyd Price

Regulatory Landscape: Regulatory Clarity: Clearer regulatory frameworks for digital health technologies will foster investor confidence and higher valuations. Companies specialising in AI-driven medical imaging, drug development, and predictive analytics are likely to see substantial valuation increases.

article thumbnail

HealthTech M&A 2025 Predictions: Europe and USA

Lloyd Price

The increasing adoption of digital health technologies, the growing importance of AI and ML, and the evolving regulatory landscape will continue to shape the deal landscape. Health IT and Interoperability: Health Information Exchange (HIE): HIE companies will continue to merge to create larger, more comprehensive networks.